<unk>  is indicated in adults with von Willebrand Disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or not indicated for the * Treatment of haemorrhage and surgical bleeding * Prevention of surgical bleeding.
Vonicog alfa
Efmoroctocog alfa
Drotrecogin alfa
Susoctocog alfa
Damoctocog alfa pegol
Etelcalcetide
Turoctocog alfa
Moroctocog alfa